Hyperliquid Strategies Inc. plan for $583M treasury boosts HYPE price
HYPE rallies toward $50 after Sonnet BioTherapeutics combines with Rorschach to launch a $583 million Hyperliquid token treasury.
Key point:
Corporate treasury buying could boost sentiment, pushing HYPE above its $50 resistance level.
Nasdaq-listed biotech company Sonnet BioTherapeutics said on Monday that it had formed a business combination with a newly created entity, Rorschach, to launch a Hyperliquid (HYPE) digital asset treasury.
